ResMed Rises 1.06% as Trading Volume Plunges to 431st, Institutional Buyers Boost Holdings Amid Analyst Upgrades and Insider Sales

On August 20, 2025, ResMed (RMD) closed with a 1.06% gain, with a trading volume of $230 million, a 28.16% decline from the previous day’s volume, ranking it 431st in market activity. Institutional investors increased their stakes in the medical device company, including BNP Paribas Asset Management, Ballentine Partners LLC, and Golden State Wealth Management, which all reported significant portfolio additions during the first quarter. These moves indicate growing confidence in ResMed’s long-term prospects despite its recent volatility.

Analysts revised their ratings and price targets in early August, with Piper Sandler, KeyCorp, and UBS upgrading their outlooks to "neutral," "overweight," and "buy," respectively. Mizuho and William Blair also raised their price targets, reflecting a consensus of moderate optimism. However, insider transactions showed mixed signals, as Director Peter Farrell and CEO Michael Farrell sold shares in July and August, reducing their ownership by 1.37% and 1.73%, respectively. These sales, while modest, could signal caution among top executives.

ResMed reported Q2 earnings of $2.55 per share, exceeding estimates by $0.08, with revenue rising 10.2% year-over-year to $1.35 billion. The company also announced a quarterly dividend of $0.60 per share, up from $0.53, reflecting its commitment to shareholder returns. Despite strong fundamentals, technical indicators showed mixed signals, including a MACD Death Cross and an ex-dividend date, which historically correlate with short-term weakness.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to the present delivered a 31.52% total return over 365 days, with a 0.98% average daily gain. The approach performed best in June 2023 (7.02%) and worst in September 2022 (-4.20%), highlighting its susceptibility to market fluctuations. While volatile, the method captured short-term momentum, making it suitable for traders targeting transient opportunities.